Skip to main content
Clinical Trials/JPRN-UMIN000010159
JPRN-UMIN000010159
Completed
未知

Effect of Haemodialysis on the Plasma glucose profile and Plasma level of Liraglutide in People with Type 2 Diabetes Mellitus and End Stage Renal Disease - Effect of Haemodialysis on the Plasma glucose profile and Plasma level of Liraglutide in People with Type 2 Diabetes Mellitus and End Stage Renal Disease

akakinen Clinic0 sites10 target enrollmentMarch 8, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes mellitus
Sponsor
akakinen Clinic
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2013
End Date
February 28, 2013
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
akakinen Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\-Type 1 Diabetes Mellitus 2\-Previous treatment with other incretin mimetics within the previous three months before screening. 3\-Insulin\-requiring type 2 Diabetes Mellitus 4\-Impaired hepatic function, measured as serum glutamic oxaloacetic transaminase \[sGOT ( Aspartate Aminotransferase , ASAT)] or serum glutamic pyruvic transaminase (sGPT) \&\#8805; 100 IU/L 5\-Unstable cardiovascular or cerebrovascular disease. 6\-Pregnant, breast\-feeding or the intention of becoming pregnant or not using adequate contraceptive measures. 7\-Female of childbearing potential who are not using adequate contraceptive menthods 8\-Known or suspected allergy to trial medication(s), excipients, or related products. 9\-Any contraindications to liraglutide.

Outcomes

Primary Outcomes

Not specified

Similar Trials